TW200505437A - Composition possessing autonomic nerve function regulating action and use thereof - Google Patents
Composition possessing autonomic nerve function regulating action and use thereofInfo
- Publication number
- TW200505437A TW200505437A TW093115090A TW93115090A TW200505437A TW 200505437 A TW200505437 A TW 200505437A TW 093115090 A TW093115090 A TW 093115090A TW 93115090 A TW93115090 A TW 93115090A TW 200505437 A TW200505437 A TW 200505437A
- Authority
- TW
- Taiwan
- Prior art keywords
- autonomic nerve
- regulating action
- nerve function
- function regulating
- composition possessing
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/12—Drugs for genital or sexual disorders; Contraceptives for climacteric disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/16—Emollients or protectives, e.g. against radiation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Obesity (AREA)
- Pulmonology (AREA)
- Epidemiology (AREA)
- Endocrinology (AREA)
- Hospice & Palliative Care (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Emergency Medicine (AREA)
- Urology & Nephrology (AREA)
- Otolaryngology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Toxicology (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Pain & Pain Management (AREA)
- Nutrition Science (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2003149361 | 2003-05-27 |
Publications (1)
Publication Number | Publication Date |
---|---|
TW200505437A true TW200505437A (en) | 2005-02-16 |
Family
ID=33487147
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TW093115090A TW200505437A (en) | 2003-05-27 | 2004-05-27 | Composition possessing autonomic nerve function regulating action and use thereof |
Country Status (8)
Country | Link |
---|---|
US (1) | US20060058376A1 (zh) |
EP (1) | EP1637136A4 (zh) |
JP (1) | JPWO2004105749A1 (zh) |
CN (1) | CN1753667A (zh) |
AU (1) | AU2004243155A1 (zh) |
CA (1) | CA2514121A1 (zh) |
TW (1) | TW200505437A (zh) |
WO (1) | WO2004105749A1 (zh) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5666760B2 (ja) * | 2005-03-31 | 2015-02-12 | サントリーホールディングス株式会社 | リグナン類化合物含有組成物 |
CA2603347C (en) * | 2005-03-31 | 2014-06-17 | Suntory Limited | Oil-in-water emulsions of lignans that exhibit improved absorption rate |
AU2006295843B2 (en) * | 2005-09-30 | 2012-04-12 | Suntory Holdings Limited | A process and an apparatus for producing episesamin-rich compositions |
JP5430927B2 (ja) | 2006-03-15 | 2014-03-05 | サントリーホールディングス株式会社 | リボフラビンとセサミン類とを含有する組成物 |
JP5069416B2 (ja) * | 2006-03-15 | 2012-11-07 | サントリーホールディングス株式会社 | 吸湿性の改善された飲食品用組成物 |
SG10201601998PA (en) * | 2006-03-31 | 2016-04-28 | Suntory Holdings Ltd Jp | Compositions containing lignan-class compounds |
US20100063142A1 (en) * | 2006-10-04 | 2010-03-11 | Toshihiro Nishiumi | o/w/o EMULSION CONTAINING LIGNAN COMPOUNDS AND COMPOSITION CONTAINING THE SAME |
US8874216B2 (en) | 2006-11-03 | 2014-10-28 | Gep Technology, Inc. | Apparatus and methods for minimally invasive obesity treatment |
SG179481A1 (en) | 2007-03-15 | 2012-04-27 | Suntory Holdings Ltd | Anti-fatigue agent |
SG10201510301UA (en) | 2007-09-19 | 2016-01-28 | Suntory Holdings Ltd | Compositions incorporating sesamin-class compounds and vitamin b1 class compounds |
WO2009038089A1 (ja) * | 2007-09-19 | 2009-03-26 | Suntory Holdings Limited | セサミン類及びビタミンeを含有する抗疲労剤 |
US8868215B2 (en) | 2008-07-11 | 2014-10-21 | Gep Technology, Inc. | Apparatus and methods for minimally invasive obesity treatment |
JP5925984B2 (ja) * | 2009-05-12 | 2016-05-25 | サントリーホールディングス株式会社 | 睡眠障害改善剤 |
JP2011178741A (ja) * | 2010-03-03 | 2011-09-15 | Pola Chemical Industries Inc | 自律神経活動活性化剤 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4427694A (en) * | 1982-06-11 | 1984-01-24 | The Vinoxen Company, Inc. | Sesamin as a psychotropic agent |
SE8703625D0 (sv) * | 1987-09-18 | 1987-09-18 | Kabivitrum Ab | New medical use |
JPH08268887A (ja) * | 1995-02-01 | 1996-10-15 | Suntory Ltd | 高血圧症又はそれに起因する医学的症状の予防又は改善剤 |
JP2003063971A (ja) * | 2001-08-23 | 2003-03-05 | Tama Seikagaku Kk | 連翹葉及びその抽出物とそれらの用途 |
-
2004
- 2004-05-27 CN CNA2004800054665A patent/CN1753667A/zh active Pending
- 2004-05-27 TW TW093115090A patent/TW200505437A/zh unknown
- 2004-05-27 CA CA002514121A patent/CA2514121A1/en not_active Abandoned
- 2004-05-27 AU AU2004243155A patent/AU2004243155A1/en not_active Abandoned
- 2004-05-27 EP EP04735099A patent/EP1637136A4/en not_active Withdrawn
- 2004-05-27 US US10/544,490 patent/US20060058376A1/en not_active Abandoned
- 2004-05-27 WO PCT/JP2004/007641 patent/WO2004105749A1/ja active Application Filing
- 2004-05-27 JP JP2005506546A patent/JPWO2004105749A1/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP1637136A1 (en) | 2006-03-22 |
CN1753667A (zh) | 2006-03-29 |
AU2004243155A1 (en) | 2004-12-09 |
JPWO2004105749A1 (ja) | 2006-07-20 |
EP1637136A4 (en) | 2007-08-01 |
WO2004105749A1 (ja) | 2004-12-09 |
US20060058376A1 (en) | 2006-03-16 |
CA2514121A1 (en) | 2004-12-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RS20060279A (en) | Synergistic fungicidal active combinations | |
TW200505437A (en) | Composition possessing autonomic nerve function regulating action and use thereof | |
IL144147A0 (en) | Regulators of the pct or smoothened pathway, compositions and uses related thereto | |
AU5338301A (en) | Methods and compositions for modulating alpha adrenergic receptor activity | |
CA2420874A1 (en) | Active ingredient combinations with insecticidal and acaricidal properties | |
WO2004021968A3 (en) | Solution for ungual application | |
ATE514418T1 (de) | Rasch zerfallende feste darreichungsformen mit nichtbröseliger konsistenz und pullulan | |
DK0703786T3 (da) | Anvendelse af nona- og dekapeptider til fremstilling af et lægemiddel til behandling af AIDS | |
AU2002361811A1 (en) | 1,3-bis-(substituted-phenyl)-2-propyn-1-ones and their use to treat disorders | |
SG146442A1 (en) | Sulphonamide derivatives, their preparation and use as medicaments | |
WO2001078703A3 (en) | Methods and compositions for modulating alpha adrenergic receptor activity | |
IL173785A0 (en) | Anti-tumor formulations comprising defibrotide alone or in combination with other anti-tumor agents | |
WO2006121717A3 (en) | Skin care compositions containing idebenone | |
WO2005013911A3 (en) | Protective and therapeutic uses for tocotrienols | |
EP1387660A4 (en) | USE OF 3-POSITION CYCLOSPORIN DERIVATIVES FOR HAIR GROWTH | |
WO2000064423A3 (fr) | Utilisation du saredutant et de ses sels pharmaceutiquement acceptables dans le traitement ou la prevention des troubles de l'humeur d'adaptation et de l'anxiete-depression | |
MXPA05007584A (es) | Composiciones de termiticida. | |
EP1560558A4 (en) | USE OF CYCLOSPORINE DERIVATIVES IN POSITION 3 FOR CAPILLARY GROWTH | |
WO2005053394A3 (de) | Synergistische insektizide mischungen | |
PL375627A1 (en) | 2-pyrrolidin-2-yl-[1,3,4]-oxadiazole derivatives and the use of the same as antidepressants | |
MXPA04003851A (es) | Antipruriticos. | |
TR200002939T2 (tr) | Paroksetin maleat | |
NZ508035A (en) | New drug combinations of A N.A.R.I., namely reboxetine and pindolol | |
WO2003013436A3 (en) | Kavalactone compositions and methods of use | |
WO2002067951A3 (de) | Verwendung von 5-substituierten nukleosiden und/oder deren prodrugs zur resistenzfreien therapie von infektionskrankheiten |